General anesthesia with remimazolam for a pediatric patient with MELAS and recurrent epilepsy: a case report
Tóm tắt
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is a mitochondrial disease. We report here the safe use of remimazolam in a pediatric MELAS patient. A 10-year-old girl (118 cm, 16 kg) was scheduled for an open gastrostomy to improve nutrition and epileptic seizure control. We induced and maintained general anesthesia with remimazolam, remifentanil, fentanyl, and rocuronium. We also performed a bilateral subcostal transversus abdominis plane block before the surgery. The surgery finished uneventfully. After we discontinued remimazolam administration, the patient woke up immediately but calmly without flumazenil. Epileptic seizures did not occur during intra- and early post-operative periods. Remimazolam enabled us to provide a pediatric MELAS patient with general anesthesia without causing delayed emergence or epileptic seizures.
Tài liệu tham khảo
Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Kärppä M, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet. 1998;63:447–54. https://doi.org/10.1086/301959.
Uusimaa J, Moilanen JS, Vainionpää L, Tapanainen P, Lindholm P, Nuutinen M, et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann Neurol. 2007;62:278–87. https://doi.org/10.1002/ana.21196.
Fricker RM, Raffelsberger T, Rauch-Shorny S, Finsterer J, Müller-Reible C, Gilly H, et al. Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency. Anesthesiology. 2002;97:1635–7. https://doi.org/10.1097/00000542-200212000-00044.
Nelson JH, Kaplan RF. Anesthetic management of two pediatric patients with concurrent diagnoses of mitochondrial disease and malignant hyperthermia susceptibility: A case report. A A Case Rep. 2017;9:204–6. https://doi.org/10.1213/XAA.0000000000000565.
Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62:690–701. https://doi.org/10.1111/j.1365-2044.2007.05055.x.
Perks A, Cheema S, Mohanraj R. Anaesthesia and epilepsy. Br J Anaesth. 2012;108:562–71. https://doi.org/10.1093/bja/aes027.
Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36:1021–7. https://doi.org/10.1002/phar.1806.
Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020;33:506–11. https://doi.org/10.1097/aco.0000000000000877.
Shioji N, Everett T, Suzuki Y, Aoyama K. Pediatric sedation using dexmedetomidine and remimazolam for magnetic resonance imaging. J Anesth. 2022;36:1–4. https://doi.org/10.1007/s00540-021-02957-1.
Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218–35. https://doi.org/10.1016/j.jclinepi.2017.04.026.
Rafique MB, Cameron SD, Khan Q, Biliciler S, Zubair S. Anesthesia for children with mitochondrial disorders: a national survey and review. J Anesth. 2013;27:186–91. https://doi.org/10.1007/s00540-012-1488-1.
Brogden RN, Goa KL. Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist. Drugs. 1991;42:1061–89. https://doi.org/10.2165/00003495-199142060-00010.
Footitt EJ, Sinha MD, Raiman JA, Dhawan A, Moganasundram S, Champion MP. Mitochondrial disorders and general anaesthesia: a case series and review. Br J Anaesth. 2008;100:436–41. https://doi.org/10.1093/bja/aen014.
Miyamoto Y, Miyashita T, Takaki S, Goto T. Perioperative considerations in adult mitochondrial disease: a case series and a review of 111 cases. Mitochondrion. 2016;26:26–32. https://doi.org/10.1016/j.mito.2015.11.004.
Sasaki H, Hoshijima H, Mizuta K. Ringer’s acetate solution-induced precipitation of remimazolam. Br J Anaesth. 2021;126:e87–9. https://doi.org/10.1016/j.bja.2020.11.021.
Hashimoto K, Sasaki T, Hachiya T, Onoguchi K, Takakura H, Oshiumi M, et al. Superior hepatic mitochondrial oxidation-reduction state in normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001;121:1179–86. https://doi.org/10.1067/mtc.2001.113599.
Finsterer J, Stratil U, Bittner R, Sporn P. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth. 1998;45:781–4. https://doi.org/10.1007/BF03012149.
Yamamoto T, Kurabe M, Kamiya Y. Re-sleeping after reversal of remimazolam by flumazenil. J Anesth. 2021;35:322. https://doi.org/10.1007/s00540-021-02915-x.
Godai K. What are mechanisms of re-sedation caused by remimazolam? J Anesth. 2021;35:466. https://doi.org/10.1007/s00540-021-02926-8.
Yamamoto T, Kurabe M, Kamiya Y. A mechanism of re-sedation caused by remimazolam. J Anesth. 2021;35:467–8. https://doi.org/10.1007/s00540-021-02930-y.
Cantineau JP, Porte F, d’Honneur G, Duvaldestin P. Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients. Anesthesiology. 1994;81:585–90. https://doi.org/10.1097/00000542-199409000-00010.
Suzuki Y, Doi M, Nakajima Y. General anesthesia with remimazolam in a patient with mitochondrial encephalomyopathy: a case report. JA Clin Rep. 2021;7:51. https://doi.org/10.1186/s40981-021-00454-8.
Kitaura A, Kosumi R, Iwamoto T, Nakao S. Remimazolam anesthesia for transcatheter mitral valve repair in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: a case report. JA Clin Rep. 2022;8:38. https://doi.org/10.1186/s40981-022-00528-1.